Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
Reset 

Neovii Pharmaceuticals AG Announces New CEO

RAPPERSWIL, Switzerland, September 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Neovii Biotech GmbH

DSM - Repurchase of Shares (1-7 September 2017)

HEERLEN, The Netherlands, September 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017

Biohaven And Alzheimer's Disease Cooperative Study (ADCS) Announce Phase 2 Clinical Trial Collaboration Evaluating Glutamate Modulating Agent Trigriluzole In Patients With Mild-To-Moderate Alzheimer's Disease

NEW HAVEN, Conn., Sept. 15, 2017 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, announced today its clinical trial collaboration... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Biohaven Pharmaceutical Holding Company Ltd

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

THOUSAND OAKS, Calif., Sept. 15, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a new analysis of the cardiovascular outcomes study (FOURIER) demonstrated that lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha(®) (evolocumab) significantly and consistently... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Amgen, Inc.

Global $6.6 Bn In-Vitro Diagnostics (IVD) Packaging Market, 2022

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Nanobiotechnology Applications, Markets and Companies 2017-2026 - Profiles of 250+ Companies & 183 Collaborations

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global Consumer and Recreational Oxygen Equipment Markets, 2023

DUBLIN, Sept. 15, 2017 /PRNewswire/ -- The "Consumer and Recreational Oxygen Equipment: Market Shares, Strategies, and Forecasts, Worldwide 2017 - 2023" report from Wintergreen Research,... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global Cardiovascular Drug Delivery Markets 2016-2026 - Technologies, Markets and Companies Report 2017

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global $39 Bn Radiation Detection Materials and Equipment Markets, 2026

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global $20 Billion Medical Robotics Market to 2022

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury

CAMBRIDGE, Mass. and MARLBOROUGH, Mass., Sept. 15, 2017 /PRNewswire/ -- BioAxone BioSciences, Inc. announced today that, as part of a collaborative effort with RXi Pharmaceuticals Corporation (NASDAQ: RXII), it is the recipient of a grant award from the National Institute of Neurological Disorders... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  RXi Pharmaceuticals Corporation

Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte

NEW YORK, September 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Clovis Oncology | Endocyte, Inc. | Dermira Inc. | Editas Medicine, Inc.

Santhera Receives Negative Opinion from the CHMP for its Marketing Authorization Application for Raxone® in DMD and Intends to Appeal this Opinion

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Santhera Pharmaceuticals (Schweiz) AG

Fagron NV: Disclosure of received notification

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Fagron Group BV

Herantis Pharma receives Life Sciences Nordic Stars Award

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017

Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Acarix A/S

CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults

KING OF PRUSSIA, Pa., Sept. 14, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved Privigen(®) [Immune Globulin Intravenous (Human),... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  CSL Behring

New indication for BRIVIACT® (brivaracetam): UCB's newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults

ATLANTA and BRUSSELS, Sept. 15, 2017 /PRNewswire/ -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for BRIVIACT(® )(brivaracetam) CV as monotherapy for partial-onset (focal) seizures (POS) in patients 16 years and... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  UCB Biopharma SPRL

DaVita Kidney Care Issues Statement about Florida Boil Water Advisory

DENVER, Sept. 14, 2017 /PRNewswire/ -- The following media statement is attributed to Dr. Martin Schreiber, vice president, clinical affairs for DaVita Kidney Care.

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
to the top ↑